Skip to main content

Think Tank. Chicago PrEP Implementation

Crowdsourcing strategies for the implementation of long-acting injectable cabotegravir (CAB-LA) for HIV prevention for sexual minority men in Chicago

Think TankIn Chicago, HIV disproportionately affects sexual minority men (SMM). To reduce HIV incidence among this key population, successful implementation of evidence-based practices is critical. Long-acting injectable cabotegravir (CAB-LA) offers a new form of HIV pre-exposure prophylaxis (PrEP) for prevention. Co-designing implementation strategies will maximize the likelihood of effective implementation of CAB-LA in Chicago. Focused on adolescent and adult SMM with particular attention to Black and Latino populations, this project has partnered with the Chicago Department of Public Health to deploy cutting-edge participatory methods that leverages input from target users in the community. The project address two specific aims:

  1. To crowdsource innovative ideas to implement CAB-LA into integrated care settings through an innovation tournament
  2. To operationalize top ideas from the innovation tournament into strategies to implement CAB-LA into integrated care settings through implementation mapping

Achievement of the study aims will produce a menu of partner-informed implementation strategies that will guide CAB-LA integration in Chicago. This approach will provide a framework for participatory methods in HIV prevention and implementation science, as well as center the voice of individuals who will benefit most.

Project Details

  • Dates: September 2023-April 2025
  • Funding Source: National Institute of Allergy and Infectious Diseases
  • Grant Number: Ending the HIV Epidemic Supplement (5P30AI117943-08 center grant)


  • Principal Investigator: Amelia Van Pelt, PhD, MPH
  • Co-Investigator: Rinad Beidas. PhD
  • Project Staff: Byrd Cook, MPH, Elizabeth Casline, PhD, MSc, Brian Mustanski, PhD